Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM

K-Number: K073279 · 2008-03-05

ApplicantVisionsense, Ltd.
Decision Date2008-03-05
Product CodeGCJ
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Visionsense, Ltd.. It received FDA 510(k) clearance on 2008-03-05 under 510(k) number K073279. The device is classified under product code GCJ. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM?

VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM is a medical device that received FDA 510(k) clearance on 2008-03-05. The listed applicant is Visionsense, Ltd.. The 510(k) number is K073279.

When did VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM receive FDA 510(k) clearance?

VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM received FDA 510(k) clearance on 2008-03-05, under 510(k) number K073279.

Who is the listed applicant for VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM?

The FDA 510(k) record lists Visionsense, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM?

The FDA product code for VS-VISIONSENSE STEREOSCOPIC VISION SYSTEM is GCJ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Visionsense, Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K223020VS3-Iridium System (VS3-IR)K210265VS3 Iridium SytemK171208Trans-anal IntroducerK153548VS3 STEREOSCOPIC HIGH DEFINITION VISION SYSTEMK131434VS3 STEREOSCOPIC HIGH DEFINITION VISION SYSTEMK123467VS3

View all 10 devices →

Related Devices (Code: GCJ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262397CuratOR EX2742Eizo CorporationK260884UNIDRIVE Select SystemKarl Storz SE & CO. KGK260972OEV-271MUH LCD Monitor;OEV-321MUH LCD Monitor;OEV-431MUH LCD MonitorSony CorporationK261139VereSee (VER150, VER200, VER151, VER201, VER200C, and VER-100-103)Freyja Healthcare, LLCK253541EZ-Close™ (EZ Close Port Site Closing Device, EZ Close MAX Port Site Closing Device, EZ Close II Port Site Closing Device)Medical ImpactK261614LED LCD Monitor (OEV-271H)Lg Electronics.Inc

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑